Healthcare provider profile · identity verified

Shruti Pathak, MD

Family Practice · BROCKTON, MA · NPI 1124301304

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	132
Amlodipine Besylate	Amlodipine Besylate	322	94
Omeprazole	Omeprazole	249	83
Lisinopril	Lisinopril	217	68
Hydrochlorothiazide	Hydrochlorothiazide	194	70
Metformin Hcl	Metformin Hcl	175	58
Gabapentin	Gabapentin	147	44
Losartan Potassium	Losartan Potassium	133	49
Furosemide	Furosemide	128	39
Albuterol Sulfate Hfa	Albuterol Sulfate	123	41
Metoprolol Succinate	Metoprolol Succinate	120	40
Tamsulosin Hcl	Tamsulosin Hcl	96	27
Fluticasone Propionate	Fluticasone Propionate	95	43
Jardiance	Empagliflozin	90	27
Trulicity	Dulaglutide	82	19
Spironolactone	Spironolactone	68	14
Metoprolol Tartrate	Metoprolol Tartrate	65	19
Pantoprazole Sodium	Pantoprazole Sodium	62	20
Tradjenta	Linagliptin	61	16
Montelukast Sodium	Montelukast Sodium	59	17
Simvastatin	Simvastatin	58	17
Eliquis	Apixaban	55	17
Ventolin Hfa	Albuterol Sulfate	55	19
Atenolol	Atenolol	52	17
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Sertraline Hcl	Sertraline Hcl	47	16
Diclofenac Sodium	Diclofenac Sodium	46	18
Levothyroxine Sodium	Levothyroxine Sodium	43	21
Amitriptyline Hcl	Amitriptyline Hcl	41	13
Glipizide	Glipizide	40	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	18
Chlorthalidone	Chlorthalidone	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Nifedipine Er	Nifedipine	36	11
Tramadol Hcl	Tramadol Hcl	36	22
Janumet	Sitagliptin Phos/Metformin Hcl	35	suppressed
Famotidine	Famotidine	34	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	16
Trazodone Hcl	Trazodone Hcl	33	14
Mirtazapine	Mirtazapine	32	11
Levetiracetam	Levetiracetam	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	11
Carvedilol	Carvedilol	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	28	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	12
Meclizine Hcl	Meclizine Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Baclofen	Baclofen	22	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Atrovent Hfa	Ipratropium Bromide	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Metformin Er Gastric	Metformin Hcl	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error